Peptides
Elecoglipron: The First Credible Oral GLP-1 Pill Clears a Phase 2 Hurdle
AstraZeneca's once-daily small molecule posts placebo-controlled weight-loss data in The Lancet — and hints at a future where the obesity revolution doesn't require a needle.